UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cancer Immunotherapy of TLR4 Agonist–Antigen Constructs Enhanced with Pathogen‐Mimicking Magnetite Nanoparticles and Checkpoint Blockade of PD‐L1

Small (Weinheim an der Bergstrasse, Germany), 2019-01, Vol.15 (4), p.e1803993-n/a

2019

Volltextzugriff (PDF)

Pretreatment with a novel Toll-like receptor 4 agonist attenuates renal ischemia-reperfusion injury

American journal of physiology. Renal physiology, 2023-05, Vol.324 (5), p.F472-F482

2023

Volltextzugriff (PDF)

Human Monocyte Subsets Are Transcriptionally and Functionally Altered in Aging in Response to Pattern Recognition Receptor Agonists

The Journal of immunology (1950), 2017-08, Vol.199 (4), p.1405-1417

2017

Volltextzugriff (PDF)

DiC14-amidine cationic liposomes stimulate myeloid dendritic cells through Toll-like receptor 4

European journal of immunology, 2008-05, Vol.38 (5), p.1351-1357

2008

Volltextzugriff (PDF)

Adjuvants containing natural and synthetic Toll-like receptor 4 ligands

Expert review of vaccines, 2013-07, Vol.12 (7), p.793-807

2013

Volltextzugriff (PDF)

Effective antibody therapy induces host-protective antitumor immunity that is augmented by TLR4 agonist treatment

Cancer Immunology, Immunotherapy, 2012-01, Vol.61 (1), p.49-61

2012

Volltextzugriff (PDF)

Ontogeny of Toll-like receptor mediated cytokine responses of human blood mononuclear cells

PloS one, 2010-11, Vol.5 (11), p.e15041-e15041

2010

Volltextzugriff (PDF)

Intestinal Bacteria Maintain Adult Enteric Nervous System and Nitrergic Neurons via Toll-like Receptor 2-induced Neurogenesis in Mice

Gastroenterology (New York, N.Y. 1943), 2020-07, Vol.159 (1), p.200-213.e8

2020

Volltextzugriff (PDF)

SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness

Nature (London), 2020-10, Vol.586 (7830), p.567-571

2020

Volltextzugriff (PDF)

Targeting toll-like receptor 4 to modulate neuroinflammation in central nervous system disorders

Expert opinion on therapeutic targets, 2019-10, Vol.23 (10), p.865-882

2019

Volltextzugriff (PDF)

Low doses of LPS exacerbate the inflammatory response and trigger death on TLR3-primed human monocytes

Cell death & disease, 2018-05, Vol.9 (5), p.499-14, Article 499

2018

Volltextzugriff (PDF)

HMGB1 Enhances the Proinflammatory Activity of Lipopolysaccharide by Promoting the Phosphorylation of MAPK p38 through Receptor for Advanced Glycation End Products

The Journal of immunology (1950), 2009-11, Vol.183 (10), p.6244-6250

2009

Volltextzugriff (PDF)

Signaling by the matrix proteoglycan decorin controls inflammation and cancer through PDCD4 and MicroRNA-21

Science signaling, 2011-11, Vol.4 (199), p.ra75

2011

Volltextzugriff (PDF)

Macrophage ABCA1 reduces MyD88-dependent Toll-like receptor trafficking to lipid rafts by reduction of lipid raft cholesterol[S]

Journal of lipid research, 2010-11, Vol.51 (11), p.3196-3206

2010

Volltextzugriff (PDF)

An endogenous caspase-11 ligand elicits interleukin-1 release from living dendritic cells

Science (American Association for the Advancement of Science), 2016-06, Vol.352 (6290), p.1232-1236

2016

Volltextzugriff (PDF)

Increased expression of interleukin 36 in chronic rhinosinusitis and its contribution to chemokine secretion and increased epithelial permeability

Cytokine (Philadelphia, Pa.), 2020-01, Vol.125, p.154798-154798, Article 154798

2020

Volltextzugriff (PDF)

Dual TLR agonist nanodiscs as a strong adjuvant system for vaccines and immunotherapy

Journal of controlled release, 2018-07, Vol.282, p.131-139

2018

Volltextzugriff (PDF)

Attenuated innate immune defenses in very premature neonates during the neonatal period

Pediatric research, 2015-11, Vol.78 (5), p.492-497

2015

Volltextzugriff (PDF)

Oxidized Phospholipid Inhibition of Toll-like Receptor (TLR) Signaling Is Restricted to TLR2 and TLR4: ROLES FOR CD14, LPS-BINDING PROTEIN, AND MD2 AS TARGETS FOR SPECIFICITY OF INHIBITION

The Journal of biological chemistry, 2008-09, Vol.283 (36), p.24748-24759

2008

Volltextzugriff (PDF)

Toll-like receptor-induced innate immune responses in non-parenchymal liver cells are cell type-specific

Immunology, 2010-03, Vol.129 (3), p.363-374

2010

Volltextzugriff (PDF)

Ethanol, TLR3, and TLR4 Agonists Have Unique Innate Immune Responses in Neuron‐Like SH‐SY5Y and Microglia‐Like BV2

Alcoholism, clinical and experimental research, 2017-05, Vol.41 (5), p.939-954

2017

Volltextzugriff (PDF)

Pyruvate Kinase M2 Regulates Hif-1α Activity and IL-1β Induction and Is a Critical Determinant of the Warburg Effect in LPS-Activated Macrophages

Cell metabolism, 2015-01, Vol.21 (1), p.65-80

2015

Volltextzugriff (PDF)

Evidence that opioids may have toll-like receptor 4 and MD-2 effects

Brain, behavior, and immunity, 2010-01, Vol.24 (1), p.83-95

2010

Volltextzugriff (PDF)

Systemic Toll-like receptor stimulation suppresses experimental allergic asthma and autoimmune diabetes in NOD mice

PloS one, 2010-07, Vol.5 (7), p.e11484-e11484

2010

Volltextzugriff (PDF)

Toll-Like Receptor-Initiated Testicular Innate Immune Responses in Mouse Leydig Cells

Endocrinology (Philadelphia), 2011-07, Vol.152 (7), p.2827-2836

2011

Volltextzugriff (PDF)

1 – 25 von 1.045

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.015)
Mit Volltextzugriff
(973)

Publikationsform

Artikel
(1.044)
Bücher
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(964)
Life Sciences & Biomedicine
(865)
Animals
(702)
Toll-Like Receptor 4 - Agonists
(643)
Humans
(566)
Mice
(508)
Toll-Like Receptor 4 - Metabolism
(431)
Immunology
(424)
Toll-Like Receptors
(356)
Lipopolysaccharides - Pharmacology
(335)
Female
(265)
Male
(253)
Cells, Cultured
(240)
Mice, Inbred C57bl
(232)
Inflammation
(222)
Toll-Like Receptor 4 - Genetics
(213)
Toll-Like Receptor 4 - Immunology
(209)
Cytokines
(201)
Signal Transduction
(191)
Tlr4 Protein
(182)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Cancer Immunotherapy of TLR4 Agonist–Antigen Constructs Enhanced with Pathogen‐Mimicking Magnetite Nanoparticles and Checkpoint Blockade of PD‐L1

Pretreatment with a novel Toll-like receptor 4 agonist attenuates renal ischemia-reperfusion injury

Human Monocyte Subsets Are Transcriptionally and Functionally Altered in Aging in Response to Pattern Recognition Receptor Agonists

DiC14-amidine cationic liposomes stimulate myeloid dendritic cells through Toll-like receptor 4

Adjuvants containing natural and synthetic Toll-like receptor 4 ligands

Effective antibody therapy induces host-protective antitumor immunity that is augmented by TLR4 agonist treatment

Ontogeny of Toll-like receptor mediated cytokine responses of human blood mononuclear cells

Intestinal Bacteria Maintain Adult Enteric Nervous System and Nitrergic Neurons via Toll-like Receptor 2-induced Neurogenesis in Mice

SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness

Targeting toll-like receptor 4 to modulate neuroinflammation in central nervous system disorders

Low doses of LPS exacerbate the inflammatory response and trigger death on TLR3-primed human monocytes

HMGB1 Enhances the Proinflammatory Activity of Lipopolysaccharide by Promoting the Phosphorylation of MAPK p38 through Receptor for Advanced Glycation End Products

Signaling by the matrix proteoglycan decorin controls inflammation and cancer through PDCD4 and MicroRNA-21

Macrophage ABCA1 reduces MyD88-dependent Toll-like receptor trafficking to lipid rafts by reduction of lipid raft cholesterol[S]

An endogenous caspase-11 ligand elicits interleukin-1 release from living dendritic cells

Increased expression of interleukin 36 in chronic rhinosinusitis and its contribution to chemokine secretion and increased epithelial permeability

Dual TLR agonist nanodiscs as a strong adjuvant system for vaccines and immunotherapy

Attenuated innate immune defenses in very premature neonates during the neonatal period

Oxidized Phospholipid Inhibition of Toll-like Receptor (TLR) Signaling Is Restricted to TLR2 and TLR4: ROLES FOR CD14, LPS-BINDING PROTEIN, AND MD2 AS TARGETS FOR SPECIFICITY OF INHIBITION

Toll-like receptor-induced innate immune responses in non-parenchymal liver cells are cell type-specific

Ethanol, TLR3, and TLR4 Agonists Have Unique Innate Immune Responses in Neuron‐Like SH‐SY5Y and Microglia‐Like BV2

Pyruvate Kinase M2 Regulates Hif-1α Activity and IL-1β Induction and Is a Critical Determinant of the Warburg Effect in LPS-Activated Macrophages

Evidence that opioids may have toll-like receptor 4 and MD-2 effects

Systemic Toll-like receptor stimulation suppresses experimental allergic asthma and autoimmune diabetes in NOD mice

Toll-Like Receptor-Initiated Testicular Innate Immune Responses in Mouse Leydig Cells

Suchergebnisse filtern